Cerebrospinal fluid markers link to synaptic plasticity responses and Alzheimer's disease genetic pathways
{{output}}
Background: Synapse loss is linked to cognitive symptoms in Alzheimer's Disease (AD) and Cerebrospinal fluid (CSF) synaptic biomarkers may clarify disease heterogeneity and disease mechanisms for progression beyond amyloid (Aβ)... ...
